Roaldi previously served as chief growth officer for UnitedHealthcare Community & State.
Author - David Miller
A setback for the Denali-Sanofi partnership
This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s...
STAT+: In stark reversal, FDA to reconsider removal of Eli Lilly...
The Food and Drug Administration on Friday said it would reconsider its decision to remove Eli...
AaviGen, SK pharmteco Announce Manufacturing Agreement for Heart...
SK pharmteco will be the preferred manufacturing partner for AVG-101, AaviGen’s lead gene therapy...
Men won all the science Nobels this year. There’s an even...
Since the Nobel Prizes were created in 1901, just 24 women have received awards in the sciences...
EMA and HMA Publish Network Strategy for Public Consultation
The draft joint network strategy for the EU until 2028 will be open for public consultation until...
A Temporary Extension for the Rare Pediatric Disease Priority...
By Mark A. Tobolowsky — The Rare Pediatric Disease Priority Review Voucher program has had a bit...
Pharma Pulse 10/14/24: Trial Site Engagement Models Poised for...
The latest news for pharma industry insiders.
STAT+: Up and down the ladder: The latest comings and goings
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot...
Opinion: Harris’ Medicare at home plan doesn’t go nearly far...
Imagine a world where your elderly mother could receive quality care at home without bankrupting...